Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
Georg Schett is Professor of Internal Medicine and, since 2006, Head of the Department of Internal Medicine 3 – Rheumatology and Immunology at Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg in Germany.
Professor Schett graduated from the University of Innsbruck in Austria in 1994. After his dissertation from medical school, he worked as a scientist at the Institute for Biomedical Aging Research of the Austrian Academy of Science in Innsbruck. Two years later, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003, he was promoted to Professor of Internal Medicine. Before accepting his position as the chair of the Department of Internal Medicine 3 in Erlangen, he worked as a scientist in the USA for 1 year.
Professor Schett’s scientific work includes a broad spectrum of clinical and immunological issues, particularly the molecular basis of immune-inflammatory diseases. Initially, he investigated the immunology of atherosclerosis and focused on antibody-mediated endothelial cell damage. His research work led to the understanding of the phenomenon of lupus erythematosus cells in 2007. He was awarded the renowned START Award in 2002 and established a research group for arthritis in Vienna. In 2008, in collaboration with colleagues, he initiated the priority program IMMUNOBONE in Germany, funded by the German Research Foundation (DFG). IMMUNOBONE aims to elucidate the interactions between the skeletal and the immune systems. Since 2015, Professor Schett has led the DFG collaborative research centre 1181 “Checkpoints for Resolution of Inflammation” in Erlangen. Additionally, he is spokesperson of the project METARTHROS, funded by the Federal Ministry of Education and Research, which investigates the impact of the metabolism on arthritis. In 2019, he received funding for the ERC-Synergy grant “4D+ nanoSCOPE Advancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscope” of which he is spokesperson. 4D+ nanoSCOPE aims to develop tools and techniques to permit time-resolved imaging and characterization of bone in three spatial dimensions (both in vitro and in vivo), thereby permitting the monitoring of bone remodelling and revolutionizing the understanding of bone morphology and its function.
In 2021, Professor Schett was appointed Vice President of Research at Friedrich-Alexander-Universität Erlangen-Nürnberg and also became a Leopoldina member of the National Academy of Sciences of Germany. His scientific work has been honoured with several awards, including the Carol-Nachman Prize from Wiesbaden. He has published over 820 peer-reviewed papers.
CP-250907 - Date of preparation: August 2022